Evidence map›Paper›PMID 40220321›Full record

ArticleBioinformatics (Oxford, England)2025

Charting the structure-sequence landscape of light chain amyloids.

Gabriele Orlando, Rodrigo Gallardo, Alicia Colla, Joost Schymkowitz, Frederic Rousseau

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Gabriele OrlandoSwitch Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, 3000, Belgium.ORCID 0000-0002-5935-5258
Rodrigo GallardoSwitch Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, 3000, Belgium.
Alicia CollaSwitch Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, 3000, Belgium.
Joost SchymkowitzSwitch Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, 3000, Belgium.
Frederic RousseauSwitch Laboratory, Department of Cellular and Molecular Medicine, KU Leuven, Leuven, 3000, Belgium.ORCID 0000-0002-9189-7399

Funding

Flanders Institute for Biotechnology C0401Fund for Scientific Research Flanders S000523NFund for Scientific Research Flanders S000722N
6 · The paper itself

Abstract

motivationLight chain amyloidosis is a disease where misfolded antibody light chains (LCs) form toxic amyloid fibrils, leading to organ damage. Although LC overproduction occurs in all cases, only certain individuals develop the disease, suggesting that specific LC sequences and properties drive amyloid formation. This process is complex, involving both protein sequence and environmental factors, but mutations that destabilize the LC fold are linked to amyloid aggregation. Despite the significance of the disease, our understanding of LC fibril formation remains limited due to the lack of extensive data and technical challenges in studying amyloid structures. To address this, a tool is needed to compare unknown LC sequences with known structures and predict which amyloids are likely to adopt new conformations, guiding experimental investigations.

resultsHMMSTUFF addresses this by using a Hidden Markov Model to generate similarity scores between LC sequences and existing PDB templates, eventually modeling the LC amyloid structures similar enough to known templates. HMMSTUFF on one side expands our understanding of LC amyloid fibril conformations, and on the other highlights the gaps in our current knowledge of LC structural space. AVAILABILITY AND IMPLEMENTATION: HMMSTUFF is available as pypi package and as source code at https://github.com/grogdrinker/hmmstuff.

Indexed as

AmyloidImmunoglobulin Light ChainsSoftwareAmino Acid SequenceDatabases, ProteinHumansMarkov ChainsModels, MolecularProtein ConformationAmyloidImmunoglobulin Light Chains

Identifiers

PMID40220321
PMCPMC12102067

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.